down arrow

Medplus Health

  • Market Cap: Mid Cap
  • Industry: Retailing
  • ISIN: INE804L01022
  • NSEID: MEDPLUS
  • BSEID: 543427
INR
788.05
29.05 (3.83%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.61 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.61 lacs (276.88%) Volume

Shareholding (Dec 2024)

FII

15.23%

Held by 124 FIIs

DII

25.65%

Held by 31 DIIs

Promoter

40.39%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.19%

  • Poor long term growth as Operating profit has grown by an annual rate 7.40% of over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.74
2

55.2% of Promoter Shares are Pledged

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Retailing

stock-summary
Market cap

INR 9,432 Cr (Mid Cap)

stock-summary
P/E

69.00

stock-summary
Industry P/E

92

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.47

stock-summary
Return on Equity

6.13%

stock-summary
Price to Book

5.55

Revenue and Profits (1 Year):
Net Sales:
1,561 Cr
(Quarterly Results - Dec 2024)
Net Profit:
46 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
17.62%
0%
17.62%
1 Year
14.73%
0%
14.73%
2 Years
13.72%
0%
13.72%
3 Years
-23.3%
0%
-23.3%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Medplus Health for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
19.12%
EBIT Growth (5y)
7.40%
EBIT to Interest (avg)
1.74
Debt to EBITDA (avg)
3.32
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.87
Tax Ratio
14.06%
Dividend Payout Ratio
0
Pledged Shares
55.20%
Institutional Holding
40.88%
ROCE (avg)
5.41%
ROE (avg)
4.21%
Valuation key factors
Factor
Value
P/E Ratio
69
Industry P/E
92
Price to Book Value
5.55
EV to EBIT
46.50
EV to EBITDA
21.57
EV to Capital Employed
4.11
EV to Sales
1.61
PEG Ratio
0.55
Dividend Yield
NA
ROCE (Latest)
7.35%
ROE (Latest)
6.13%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

55.1957

Mutual Funds

Held by 17 Schemes (21.51%)

FIIs

Held by 124 FIIs (15.23%)

Promoter with highest holding

Lone Furrow Investments Private Limited (14.46%)

Highest Public shareholder

Nippon Life India Trustee Ltd-a/c Nippon India Mul (7.39%)

Individual Investors Holdings

13.21%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -0.93% vs 5.87% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 18.46% vs 169.78% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,561.45",
          "val2": "1,576.17",
          "chgp": "-0.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "132.53",
          "val2": "124.44",
          "chgp": "6.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "25.97",
          "val2": "25.12",
          "chgp": "3.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "45.89",
          "val2": "38.74",
          "chgp": "18.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.49%",
          "val2": "7.90%",
          "chgp": "0.59%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 13.82% vs 27.37% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 189.37% vs 87.82% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,065.00",
          "val2": "2,692.89",
          "chgp": "13.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "218.21",
          "val2": "156.44",
          "chgp": "39.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "49.77",
          "val2": "46.81",
          "chgp": "6.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "53.10",
          "val2": "18.35",
          "chgp": "189.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.12%",
          "val2": "5.81%",
          "chgp": "1.31%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 11.90% vs 25.11% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 208.57% vs 38.40% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,626.45",
          "val2": "4,134.36",
          "chgp": "11.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "350.74",
          "val2": "248.22",
          "chgp": "41.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "75.74",
          "val2": "71.31",
          "chgp": "6.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "98.99",
          "val2": "32.08",
          "chgp": "208.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.58%",
          "val2": "6.00%",
          "chgp": "1.58%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 23.42% vs 20.59% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 31.57% vs -48.06% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,624.86",
          "val2": "4,557.58",
          "chgp": "23.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "354.08",
          "val2": "265.68",
          "chgp": "33.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "96.43",
          "val2": "83.03",
          "chgp": "16.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "65.47",
          "val2": "49.76",
          "chgp": "31.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.29%",
          "val2": "5.83%",
          "chgp": "0.46%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
1,561.45
1,576.17
-0.93%
Operating Profit (PBDIT) excl Other Income
132.53
124.44
6.50%
Interest
25.97
25.12
3.38%
Exceptional Items
0.00
0.00
Consolidate Net Profit
45.89
38.74
18.46%
Operating Profit Margin (Excl OI)
8.49%
7.90%
0.59%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -0.93% vs 5.87% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 18.46% vs 169.78% in Sep 2024

Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
3,065.00
2,692.89
13.82%
Operating Profit (PBDIT) excl Other Income
218.21
156.44
39.48%
Interest
49.77
46.81
6.32%
Exceptional Items
0.00
0.00
Consolidate Net Profit
53.10
18.35
189.37%
Operating Profit Margin (Excl OI)
7.12%
5.81%
1.31%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 13.82% vs 27.37% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 189.37% vs 87.82% in Sep 2023

Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
4,626.45
4,134.36
11.90%
Operating Profit (PBDIT) excl Other Income
350.74
248.22
41.30%
Interest
75.74
71.31
6.21%
Exceptional Items
0.00
0.00
Consolidate Net Profit
98.99
32.08
208.57%
Operating Profit Margin (Excl OI)
7.58%
6.00%
1.58%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 11.90% vs 25.11% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 208.57% vs 38.40% in Dec 2023

Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
5,624.86
4,557.58
23.42%
Operating Profit (PBDIT) excl Other Income
354.08
265.68
33.27%
Interest
96.43
83.03
16.14%
Exceptional Items
0.00
0.00
Consolidate Net Profit
65.47
49.76
31.57%
Operating Profit Margin (Excl OI)
6.29%
5.83%
0.46%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 23.42% vs 20.59% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 31.57% vs -48.06% in Mar 2023

stock-summaryCompany CV
About Medplus Health Services Ltd stock-summary
stock-summary
Medplus Health Services Ltd
Mid Cap
Retailing
MedPlus Health Services Limited was incorporated as a Private Limited Company with the name 'MedPlus Health Services Private Limited' at Hyderabad on 30 November, 2006. The Company converted from a Private Limited Company to a Public Limited Company, pursuant to a Special Resolution passed by Shareholders at the Extra Ordinary General Meeting held on 01 June 2021 and name of the Company was changed to MedPlus Health Services Limited on 28 June 2021.
Company Coordinates stock-summary
Icon
No Company Details Available